The GA733-2 antigen is a cell surface glycoprotein highly expressed on most human gastrointestinal carcinoma and at a lower level on most normal epithelia. It is an unusual cell-cell adhesion protein that does not exhibit any obvious relationship to the four known classes of adhesion molecules. In this study, the disulfide-bonding pattern of the GA733-2 antigen was determined using matrix-assisted laser desorption/ionization mass spectrometry and N-terminal sequencing of purified tryptic peptides treated with 2-[2-nitrophenylsulfonyl]-3-methyl-3-bromoindolenine or partially reduced and alkylated. Numbering GA733-2 cysteines sequentially from the N terminus, the first three disulfide linkages are was not glycosylated, whereas Asn 88 was completely glycosylated, and Asn 51 was partially glycosylated. These data show that the extracellular domain of the GA733-2 antigen consists of three distinct domains; a novel cysteine-rich N-terminal domain (GA733 type 1 motif), a cysteine-rich thyroglobulin type 1A domain (GA733 type 2 motif), and a unique nonglycosylated domain without cysteines (GA733 type 3 motif).
correlate high GA733-2 expression with malignant tumor development in other types of cancer lesions, raising intriguing questions about the role of this antigen in tumor progression (for review see Ref. 10) .
The GA733-2 antigen was originally defined by the CO17-1A monoclonal antibody (mAb) and GA733 mAb (11, 12) . Because a randomized phase II trial with mAb CO17-1A in colorectal carcinoma patients has demonstrated a significant decrease in recurrence and mortality of mAb-treated patients versus control patients (13, 14) , GA733-2 antigen has attracted substantial attention as a target for immunotherapy for treating human carcinomas. More recently, it has been reported that a recombinant adenovirus expressing the full-length GA733-2 antigen has the capability to induce humoral, cellular, and protective immunity to the antigen resulting in significant and specific inhibition of the colorectal carcinoma cell growth in mice, which implies that this recombinant adenovirus may have potential as a vaccine for colorectal carcinoma patients (15) .
The GA733-2 antigen has been shown to function as a calcium-independent homophilic cell adhesion molecule that does not exhibit any apparent homology to the four known cell adhesion molecule superfamilies (16) . Although the functional consequence of GA733 antigen-mediated adhesion on tumorigenesis is unclear, emerging evidence correlates increased GA733-2 antigen expression with increased cell proliferation and a less differentiated cell phenotype as demonstrated in cervical intraepithelial neoplasia (17) .
The GA733-2 gene encodes for a 314-amino acid polypeptide that includes a 23-amino acid signal sequence, a 242-amino acid extracellular domain, a 23-amino acid transmembrane domain, and a 26-amino acid cytoplasmic domain (18) . The extracellular domain of GA733-2 antigen (GA733-2EC) has three potential N-linked glycosylation sites and an N-terminal cysteine-rich region containing 12 cysteines. It has been proposed that this N-terminal portion is comprised of an epidermal growth factor (EGF)-like motif followed by a thyroglobulin type 1A motif based on relatively weak homology (19, 20) . However, structural evidence to support this hypothesis has not yet been reported. In addition, analysis of glycosylation sites on the GA733-2 antigen is of interest because changes in glycoprotein glycosylation typically accompany malignant transformation (for review see Ref. 21) . For example, a recent study showed that modulation of the glycosylation of CD44 regulated cell adhesion during tumor growth and metastasis (22) . Two of the three possible N-glycosylation sites in GA733-2EC are located in the N-terminal cysteine-rich region, which appears to contain the epitope for the CO17-1A mAb used in the clinical trial described above (10) . Hence, it is likely that N-glycosylation of GA733-2 antigen may play roles in cell adhesion and/or tumor targeting. A better understanding of the special features of the GA733-2 antigen may provide insights into the function(s) of this antigen and should facilitate the rational design of mutants for structure-function studies.
In this study, we determined the linkages of the six disulfide bonds and the sites of N-linked glycosylation in GA733-2EC using MALDI-MS and N-terminal sequencing of purified peptides. The data show that the cysteine-rich region has two distinct domains with six cysteines forming three disulfides in each domain. Surprisingly, the first cysteine-rich domain does not belong to the EGF-like domain family as previously predicted (10, 19, 20) . Instead, it has a unique disulfide linkage pattern. In contrast, assignment of disulfides in the second cysteine-rich domain is in agreement with the disulfide pattern of a thyroglobulin type 1A motif, recently determined in insulin-like growth factor-binding protein-1 and 6 (23) , and consistent with its apparent sequence homology (20, 24) . Of the three potential N-glycosylation sites, Asn 51 was partially glycosylated, Asn 88 was completely glycosylated, and Asn 175 did not contain any carbohydrate moieties.
EXPERIMENTAL PROCEDURES
Materials-Immobilized tosylphenylalanine chloromethylketonetrypsin F7m columns were purchased from MoBiTec (Marco Island, FL). Trypsin (sequencing grade) was purchased from Promega (Madison, WI). N-Glycosidase A was obtained from Roche Molecular Biochemicals. Tris-(2-carboxyethyl)-phosphine (TCEP) and 2-(2Ј-nitrophenylsulfonyl)-3-methyl-3-bromoindolenine (BNPS-skatole) were obtained from Pierce. Pyroglutamate aminopeptidase was obtained from Panvera (Madison, WI). Reagents for PAGE were obtained from Bio-Rad. All other reagents were either high performance liquid chromatography (HPLC) grade or the highest quality analytical reagent grades available.
Purification of GA733-2EC-Recombinant GA733-2EC was produced in Hi Five insect cells using the baculovirus system as previously described (25, 26) . The secreted GA733-2EC was purified from the culture supernatant using a GA733 mAb-Sepharose affinity column. The column was washed with PBS (10 mM sodium phosphate, 130 mM NaCl, pH 6.0), and proteins were eluted with 50 mM glycine-HCl, pH 2.5. The pH of the peak fractions was immediately raised to approximately pH 6 using 2 M Tris-HCl, pH 6.0, followed by dialysis against PBS. Protein samples were concentrated to 7-8 mg/ml using Centriprep and Centricon concentrators with a 10-kDa molecular mass cut-off membrane (Amicon, Beverly, MA). The concentrated protein solution was then injected into two TSK columns G3000 SW XL and G2000 SW XL (Toso-Haas, Japan) connected in series and separated at 0.8 ml/min using PBS, pH 6.0. The quality of purification was monitored by SDS-PAGE and Western blot analysis using the GA733 mAb. The concentration of GA733-2EC was determined by A 280 in a 1-cm pathlength cell, using a molar absorption coefficient (⑀ g/l ) of 0.926, calculated from the GA733-2EC sequence according to Pace et al. (27) .
Protease Digestion-For disulfide assignments, a tosylphenylalanine chloromethylketone-trypsin F7m column was used for initial fragmentation of GA733-2EC after equilibrating the column with 10 ml of 50 mM sodium phosphate, 3 M urea, pH 6.5, at 22°C. Purified GA733-2EC (400 g/134 l) was treated with urea (final concentration, 3 M) and loaded onto the trypsin column. The protein solution percolated through the column by gravity over the period of ϳ1 h, and the eluate was reloaded a total of six times followed by overnight incubation in the column without flow at 22°C. The column was then centrifuged at 2,000 rpm for 5 s to collect the digested peptide. Residual peptides were removed with two successive elutions using 200-l aliquots of 50 mM sodium phosphate, 3 M urea, pH 6.5, followed by centrifuging at 2,000 rpm for 5 s.
Mild Trypsin Digestion in Solution for Carbohydrate Analysis-GA733-2EC was digested with trypsin in solution under physiological conditions at a ratio of 1:500 (w/w) enzyme to substrate at 37°C for 1 h. The reaction was stopped by adding phenylmethylsulfonyl fluoride (final concentration, 0.15 mM). The sample was denatured and reduced by adding 7 M urea and 10 mM TCEP (final concentration) followed by incubation at 37°C for 30 min. The fragments were separated by HPLC gel filtration using two TSK columns G3000 SW XL and G2000 SW XL connected in series with 0.6 ml/min flow rate in 7 M urea, 20 mM Tris-Cl, 1 mM TCEP, pH 7.0. Collected fractions were immediately dialyzed against 10 mM sodium phosphate, pH 7.0, to remove urea and TCEP.
Reverse Phase HPLC Separation of Peptides-Peptides were separated by reverse phase (RP)-HPLC on a ZORBAX 300SB-C18 column (2.1-mm inner diameter ϫ 150 mm, Hewlett Packard Co.) using a System Gold HPLC (Beckman, Fullerton, CA) at a flow rate of 0.2 ml/min. Various gradient conditions were used as described in figure legends with solvent A (0.1% trifluoroacetic acid in water) and solvent B (0.085% trifluoroacetic acid in 95% acetonitrile). Where required, tryptic digests were reduced prior to RP-HPLC by adding 20 mM TCEP in 100 mM ammonium bicarbonate, pH 8.0. The mixture was incubated at 37°C for 1 h, and 2% trifluoroacetic acid (final concentration) was then added prior to injection onto the HPLC column. Deglycosylation and BNPS-skatole Cleavage-The purified tryptic fragment containing glycosylation (T1) was treated with N-glycosidase A. The peptide solution (3 g/250 l in 50 mM sodium acetate, pH 5.0) was mixed with 14 l of N-glycosidase A (0.1 g/l stock solution). The mixture was then incubated overnight at 37°C followed by RP-HPLC to separate deglycosylated peptide. Deglycosylated T1-N (1.4 g) in the presence of 5 M guanidine-HCl was cleaved with BNPS-skatole essentially as previously described (28) .
Partial Reduction with TCEP and Cleavage of N-terminal Pyroglutamic Acid-TCEP partial reduction of complexes with multiple disulfides was performed as previously described (29). The purified peptide complex (100 pmol/70 l in 0.1% trifluoroacetic acid) was mixed with the same volume of 50 mM TCEP in 50 mM citrate, pH 3.5, and incubated for 3 min at 22°C. Alkylation of peptides was performed by adding the TCEP-reduced peptide solution into the same volume of 1 M iodoacetamide in 100 mM HEPES, 1 mM EDTA, pH 7.5, followed by incubation for 30 min at 37°C. The reaction was stopped by adding 1.3% trifluoroacetic acid (final concentration). Pyroglutamate aminopeptidase (1.3 milliunits/6.3 l) was added to the peptide solution (33 pmol/50 l in 50 mM sodium phosphate, 1 M guanidine-HCl, 10 mM dithiothreitol, 1 mM EDTA, pH 7.0) and incubated overnight at 60°C to remove N-terminal pyroglutamic acid from the purified partially reduced and alkylated peptides.
N-terminal Sequence Analysis-Automated Edman degradation was performed using an Applied Biosystems model 494 protein sequencer as previously described (30) .
Mass Spectrometry-Molecular mass determination was performed by MALDI-time of flight mass spectrometry using a Voyager DE-PRO mass spectrometer (PerSeptive Biosystems, Framingham, MA). The accelerating voltage was set to 20 kV. Data were acquired either in the linear or reflector mode of operation. Spectra were externally calibrated with protein A (44,614 Da), chymotrypsinogen (25,657.1 Da), ubiquitin (8, 567 .49 Da), insulin ␤ chain (3,496.96 Da), and bradykinin (1,061.24 Da). Intact GA733-2EC and the tryptic 22-kDa fragment from partial digestion in solution (10 pmol/2 l) were mixed 1:1 with a saturated solution of 3,5-dimethoxy-4-hydroxycinnamic acid (sinapinic acid, Sigma) in 33% acetonitrile and 0.1% trifluoroacetic acid. The 6-kDa fragment from partial tryptic digestion of GA733-2EC in solution was analyzed using ␣-cyano-4-hydoxy cinnamic acid (Sigma) in 33% acetonitrile and 0.1% trifluoroacetic acid as the matrix. Peptides with molecular masses smaller than 5 kDa were directly applied to the MS sample plate that was precoated with a saturated solution of nitrocellulose and ␣-cyano-4-hydoxycinnamic acid (1:4 w/w) in 2-propanol and acetone (1:1 v/v) as previously described (31) .
RESULTS
Protein Purification, Signal Removal, and Characterization of GA733-2EC-The recombinant extracellular domain of GA733-2 (GA733-2EC) was purified from Hi Five insect cell culture supernatant by GA733 mAb-Sepharose affinity chromatography followed by HPLC gel filtration. The purified protein migrated on SDS-PAGE as a diffuse doublet with apparent masses of ϳ31 and 33 kDa (Fig. 1) . MALDI-MS analysis of purified GA733-2EC showed two broad peaks with average masses (MH ϩ ) of 28,332 and 29,349 Da. Because the calculated mass of the GA733-2EC is 27,372 Da after removal of the signal peptide, these data suggest that the molecule is heterogeneously glycosylated, resulting in two major populations with average carbohydrate masses of about 960 and 1,977 Da. The broad peak shapes of the doublet in the mass spectrum are indicative of additional mass heterogeneity of these two major populations of molecules. N-terminal sequence analysis of GA733-2EC indicated that the majority of the protein has a blocked N terminus, although a low level sequence representing about 1% of the protein amount loaded to the sequencer was detected. The low level sequence (AAQEEC . . . ) indicated a minor alternative cleavage of the signal peptide after residue 21 of the unprocessed full-length protein. Subsequent MALDI-MS analysis and pyroglutamate aminopeptidase digestion of tryptic T2 peptide complex (Tables I and III) showed that the predominant signal peptide cleavage occurred after residue 23 and the N terminus of the mature protein is pyroGlu (see below). Hence the amino acid residues of the mature protein are numbered starting with this pyroGlu residue (Fig. 2) . The GA733-2EC eluted from the HPLC gel filtration column as a single symmetrical peak between the 44-and 17-kDa protein standards. Rechromatogrphy of the protein at high and low protein concentrations yielded consistent elution volumes (data not shown). These data suggest that recombinant GA733-2EC is a globular monomer with a native-like fold.
Isolation of Disulfide-linked Tryptic Peptide Complexes-A representative RP-HPLC chromatogram of a GA733-2EC digest using an immobilized trypsin column after reduction (Fig.  3A) is compared with the chromatogram of a replicate aliquot that was not reduced prior to RP-HPLC (Fig. 3B ). All peaks in the nonreduced chromatogram and most peptides in the reduced chromatograms were analyzed by MALDI-MS. Peptides that could not be unambiguously identified by mass analysis were subjected to Edman sequencing (data not shown). Three major peaks and several minor peaks observed in the nonreduced digest (T1-T3, T2*, and T3* in the reduced digest, indicating that they contained disulfidelinked peptides. In addition, several new peaks appeared in the reduced tryptic digest chromatogram that corresponded to cysteine-containing peptides released from disulfide linkages by reduction. The identities of these peptides are indicated by inclusive residue numbers of the GA733-2EC sequence (Fig. 3,  A and B) . Peaks T1-T3 from the nonreduced tryptic digest were further analyzed to determine the disulfide linkages in GA733-2EC. T2* and T3* were identified as incomplete cleavages of T2 and T3, respectively.
Overview of Disulfide Linkage Determination-MALDI-MS and Edman sequencing analyses of the tryptic peptide complexes shown in Fig. 3B are summarized in Table I (Fig. 3, A and B Fig. 3C shows a summary of additional processing of the T1 and T2 complexes to complete disulfide assignments of these complexes. To minimize complexity in data analysis, T1 was deglycosylated with N-glycosidase A. BNPSskatole cleavage of deglycosylated T1 (T1-N in Fig. 3C ) was subsequently performed to obtain peptides containing one disulfide bond each. Partial reduction with TCEP and alkylation with iodoacetamide were performed for T2, which contained three disulfide bonds. One disulfide bond in T2 was assigned by Edman sequencing of the T2-R5 peak (Fig. 3C) . Subsequently, pyroglutamate aminopeptidase was used to remove the N-terminal pyroglutamate from T2-R3, making it possible to carry out Edman sequencing and complete disulfide assignments of T2. Using this strategy it was possible to establish the disulfide bonds as: Cys 4 3 . Chromatographic identification of disulfide-linked tryptic peptides and summary of GA733-2EC disulfide bond determination. A, chromatographic separation of GA733-2EC tryptic digest (45 g) after reduction with TCEP on a ZORBAX 300SB-C18 column as described under "Experimental Procedures" using the following gradient conditions; 2% B for 5 min; 2-32% B over 75 min; 32-60% B over 35 min. B, chromatographic separation obtained with 90 g of GA733-2EC tryptic digest (not reduced) using the same gradient as in A. Major peaks, which disappeared following reduction, are indicated by T1-T3. T1 is comprised of two disulfide-linked polypeptide chains, 84 -102 and (103)104 -115. T2 consists of two disulfide-linked polypeptide chains, 1-10 and 11-38, and T3 consists of two disulfide-linked polypeptide chains, 43-47 and 59 -83. T2* and T3* indicate incomplete tryptic cleavages of T2 and T3, respectively. Single peptides that appear as a result of reduction are indicated in A by their inclusive residue numbers. C, summary of strategy used to complete GA733-2EC disulfide bond assignments. T1 was deglycosylated with N-glycosidase A and further cleaved chemically with BNPS-skatole. Partial reduction with TCEP and alkylation was performed for T2 followed by enzymatic deblocking of the N-terminal pyroglutamate. Each peak is named after the reagent and protease used as well as with the peak number after RP-HPLC. T, trypsin (cleavage after K or R); N, N-glycosidase A; S, BNPS-skatole (cleavage after W); R, partial reduction and alkylation; P, pyroglutamate aminopeptidase (cleavage after pyroGlu).
The carbohydrate in T1 were completely removed by N-glycosidase A, indicating that all the carbohydrate in this peptide complex was located on Asn 88 (Table II) . RP-HPLC purified deglycosylated T1 (T1-N) was used for all subsequent experiments. Because T1-N has two disulfide bonds with one of these two disulfide bonds linking the two tryptic peptides, a further cleavage was necessary to generate peptide complexes containing only one disulfide bridge each for direct assignment. BNPSskatole cleavage was carried out to cleave T1-N at Trp 94 . Fig.  4B shows that BNPS-skatole treatment generated multiple products (T1-N-S1 to S7). MALDI-MS and Edman sequencing analyses were used to characterize all peaks. T1-N-S1 was shown to be Ala (Table II) . Because T1-N-S1 and T1-N-S2 each have only a single disulfide bond, it was possible to assign the disulfide bonds Cys 87 -Cys 93 and Cys 95 -Cys 112 for the T1 complex. T1-N-S1 showed a mass 13.5 Da greater than that expected for Ala 84 -Trp 94 (Table II) , consistent with the formation of an oxolactone by oxidative halogenation of the C terminus of the tryptophanyl-cleaved peptide as reported by Rahali and Gueguen (32) .
To characterize T1-N-S4 to S7, peak fractions were analyzed by MALDI-MS after reduction with TCEP to get more precise molecular masses. Although T1-N-S4 and T1-N-S6 eluted as separate peaks in RP-HPLC (Fig. 4B) , MALDI-MS spectra of these two fractions were identical within expected error and indicated that both fractions were the uncleaved T1-N species with a mass increase of 15.7 Da on the Ala 84 -Arg 102 peptide (Table II) . This is consistent with oxidation of the indole ring of tryptophan in incomplete BNPS-skatole cleavage of peptides, which results in a 16-Da mass increase (32) . T1-N-S5 and T1-N-S7 were also uncleaved T1-N molecules with a 49.4-Da mass increase on the Ala 84 -Arg 102 peptide (Table II) , which is most likely due to oxidation of Trp 94 by addition of three oxygen atoms. The differing elutions of T1-N-S4 and T1-N-S6 on RP-HPLC and their identical masses suggested that they represented two different constrained conformations of the oxidized indole ring of Trp 94 . To test this hypothesis, fraction T1-N-S4 was isolated following RP-HPLC, incubated at 37°C for 30 min, and then rechromatographed using the same gradient. Indeed, the RP-HPLC chromatogram showed partial conversion to a later elution peak T1-N-S4Љ that correspond to the elution position of T1-N-S6 (Fig. 4C) . MALDI-MS analysis confirmed that there was no mass difference between T1-N-S4Ј and T1-N-S4Љ (data not shown).
Analysis of T2-The disulfide assignments for the T2 complex were obtained by characterization of partially reduced and alkylated peptides using Edman sequencing. The T2 peptide complex is comprised of pyroGlu 1 -Lys 10 and Leu 11 -Lys 38 , having one intrapeptide disulfide bond in Leu 11 -Lys 38 and two inter-peptide disulfide bonds (Table I ). This peptide fraction was subjected to partial reduction using TCEP followed immediately by alkylation with iodoacetamide and subsequent separation by RP-HPLC. The use of the strong reducing agent, TCEP, which reduces disulfides at low pH within a short incubation time, had been shown to minimize both thiol-disulfide exchange and disulfide rearrangement in the partially reduced peptides (29). The RP-HPLC analysis of multiple peaks of T2 following partial reduction and alkylation is shown in Fig. 5 and results from MALDI-MS and Edman sequencing analyses are summarized in Table III . Peptide T2-R2 is the original 38 , with one alkylated cysteine on each peptide. Because the N-terminal pyroglutamate prevented Edman sequencing, it was necessary to remove this group prior to Edman sequencing to determine which cysteine side chains had been modified. Pyroglutamate aminopeptidase treatment of T2-R3 was performed under reducing condition using 10 mM dithiothreitol, generating Glu 2 -Lys 10 (T2-R3-P1) and Leu 11 -Lys 38 (T2-R3-P2). After this treatment both peptides were completely reduced, but the single cysteine in each peptide that was alkylated prior to pyroglutamate aminopeptidase treatment could be identified by Edman sequencing (Fig. 5C ). When dithiothreitol was omitted from the enzyme reaction buffer, no cleavage of the N-terminal pyroglutamate occurred. Table III) . Similarly, the two reduced and alkylated residues, Cys 6 and Cys 36 identified in T2-R3, represent the remaining disulfide bond. Although the peak fraction labeled with an asterisk in Fig. 5B also showed a molecular mass indicative of T2 with two alkylated cysteines, the amount of the species was negligible compared with the major species (T2-R3), and it was not analyzed further. Therefore, the partial reduction/ alkylation of the T2 peptide complex indicated that three disulfide bonds assignments are Cys 4 were not found in RP-HPLC fractions from trypsin column digestion (Fig. 3, A and B) , Asn 88 is completely glycosylated. Peptides were chromatographed on a ZORBAX 300SB-C18 column as described under "Experimental Procedures" using the following gradient conditions: 2% B for 15 min; 2-10% B over 5 min; 10 -35% B over 62 min. A, T2 control before partial reduction and alkylation. B, T2 after partial reduction with TCEP and alkylation. The analysis of each peak is summarized in Table III . The small peak marked with asterisks showed the molecular mass of T2 with two alkylated cysteines by MALDI-MS, although the amount of this species was negligible compared with the major species with two alkylated residues, T2-R3. C, pyroglutamate aminopeptidase treatment of T2-R3 generating free Nterminal T2-R3-P1 peptide. The peak marked with an arrow was in the pyroglutamate aminopeptidase control.
The variable masses of the carbohydrate moiety on Asn 88 are consistent with the average mass increase of 960 Da observed for the major GA733-2EC species compared with its sequence mass.
The other two potential N-glycosylation sites were evaluated using fragments from mild tryptic digestion of GA733-2EC in physiological solution. This partial digestion resulted in three products when separated under reducing conditions on a SDS gel: a 22-kDa band, an 8-kDa band, and a 6-kDa band (Fig. 6B) . This cleavage site is located at Arg 57 , Arg 58 in a proteasesensitive loop that has been previously reported to lead to release of an ϳ6-kDa peptide from the N terminus of the protein (33, 34) . These fragments were separated by HPLC gel filtration under reducing and denaturing conditions (Fig. 6C) . MALDI-MS analysis of the larger fragment (fraction I) showed a mass of 21,953 Da, which is within experimental error of the sum of the calculated mass of Ala 59 -Lys 242 and the average mass of the carbohydrate moiety on Asn 88 as described above (21,968 Da expected versus 21,953 Da observed). These data indicate that the partial tryptic 22-kDa fragment cannot contain additional glycosylation on either Asn 175 or Ser/Thr side chains.
The MALDI-MS spectrum of fraction II in Fig. 6C showed two clusters of masses (Fig. 6D) . The masses at 6,232.7 and 6,388.1 Da correspond to pyroGlu 1 -Arg 57 and pyroGlu 1 -Arg 58 , respectively, with no N-linked or O-linked carbohydrate. The third peak (6,533.7 Da) in the first cluster apparently represents a small amount of protein with an alternative N terminus caused by variable cleavage of the signal peptide that results in an additional two alanines at the N terminus (see above). The second cluster of peaks shows masses 1,034 -1,037 Da higher than the corresponding peaks in the first cluster, indicating that the smaller mild tryptic fragment is only partially glycosylated on Asn 51 . Because MS is not quantitative, the relative staining intensities of the 6-and 8-kDa bands, although consistent with the MS signal intensities, are more reliable indicators that only a small proportion of the protein is glycosylated at Asn 51 . Interestingly, the carbohydrate moiety on this site appears to be less variable in mass than the carbohydrate groups on Asn 88 . Finally, the sum of observed masses for glycosylations on Asn 88 (960 Da) and Asn 51 (1,034 Da) is 1,994 Da, which is close to the 1,977-Da difference between calculated mass and observed mass for the minor higher mass peak in the intact GA733-2EC MALDI-MS spectrum.
DISCUSSION
The disulfide bonds in recombinant GA733-2 antigen have been determined by a combination of MALDI-MS, peptide mapping, and N-terminal sequencing. All peptide cleavage, deglycosylation, and purification steps were carried out below pH 6.5 to prevent disulfide scrambling. The disulfide-bonding pattern in the GA733-2 antigen is summarized in Fig. 2 . A 200-l immobilized trypsin column was chosen for the primary protease treatment in these studies because its highly concentrated immobilized enzyme on the matrix surface facilitated proteolysis with no appreciable contamination of reaction solutions with enzyme degradation products.
Assignments of the disulfide linkages in the T1 (Ala 84 -Arg 102 /Thr 104 -Arg 115 ) and T2 (pyroGlu 1 -Lys 10 /Leu 11 -Lys 38 ) tryptic peptide complexes were not straightforward because they contained four and six cysteines, respectively. In initial experiments, proteolytic cleavages of deglycosylated T1 (T1-N) and T2 were performed using various proteases including chymotrypsin, pepsin, subtilisin, elastase, and thermolysin in the presence of 1 M guanidine-HCl. However, both complexes were fairly resistant to further proteolysis under all conditions evaluated, and informative cleavages between neighboring cysteines were not obtained. Partial reduction of T1-N with TCEP followed by alkylation was then used to attempt determination of disulfide bond assignments. The results of these experiments established that Cys 87 was disulfide linked to either Cys 93 or Cys 95 , but disulfide scrambling was extensive even when reaction times and pH were lowered (data not shown). Subsequently, BNPS-skatole cleavage provided unambiguous disulfide assignments for T1-N. Although several competing side reactions occurred that resulted in modifications of the peptides without cleavage at the tryptophan, there was no indication of disulfide rearrangement. Partial reduction with TCEP followed by alkylation was performed for T2, and no significant disulfide scrambling occurred with this complex. After removing the N-terminal pyroglutamate with pyroglutamate aminopeptidase, Edman sequencing of both alkylated peptides were performed, and the disulfide linkages in T2 were unambiguously determined.
Prior reports concluded that the extracellular domain of GA733-2 antigen consisted of a N-terminal cysteine-rich region comprised of an EGF-like domain followed by a thyroglobulin type 1A motif and a cysteine-free region with no apparent homology to other proteins outside of the GA733 protein family based on sequence homology and cysteine spacing (19, 20) . The disulfide linkages of GA733-2 antigen determined experimentally in the present study are compared with those of other cysteine-rich domains in Fig. 7 (36, 38) .
It has been reported that treatment of colon cancer cells in culture with N-glycosylation inhibitor, tunicamycin, resulted in a reduced migration on SDS-PAGE of GA733-2 antigen that was consistent with the sequence predicted mass, whereas treatment with an O-glycanase showed no effects, suggesting that carbohydrates in GA733-2 are predominantly or exclusively N-linked (33, 34) . Our data now confirm that the carbohydrate moieties on the GA733-2 antigen are N-linked with no evidence of O-linked carbohydrate moieties. The extracellular domain of GA733-2 antigen has three potential N-glycosylation sites on asparagine residues 51, 88, and 175 (Fig. 2) . Through analysis of T1, we found that Asn 88 is completely glycosylated with carbohydrate moieties ranging in size from about 893 to 1,259 Da, which accounts for the average 960-Da mass difference between the calculated mass of the GA733-2EC sequence and the major peak observed using MALDI-MS. Because GA733-2EC has a proteolytic cleavage sensitive site on Arg 58 (18) , purified GA733-2EC was subjected to mild tryptic digestion to generate the N-terminal 6 -8-kDa fragment containing Table I ), which explains the 960-kDa mass difference between the sequence mass and the major observed mass of GA733-2EC. B, partial tryptic digests were separated on 15% Tris-Tricine gels under reducing conditions and stained with Coomassie Blue. Lane 1, purified GA733-2EC; lane 2, partial digestion with trypsin in PBS (E: S ϭ 1: 500) at 37°C for 1 h. The positions of standard proteins in kDa are shown on the left. The solid and dashed arrows indicate the apparent 6-and 8-kDa bands, respectively. C, HPLC gel filtration chromatography of GA733-2EC after partial tryptic digestion using a TSK G3000 SW XL and a G2000 SW XL column connected in series under reducing and denaturing conditions. Peaks I and II were pooled separately and analyzed by MALDI-MS after dialysis to remove the buffer, reducing reagent, and urea. 
Disulfide Structure and N-Glycosylation Sites of GA733-2
likely that a minor diffuse 8-kDa band on a SDS gel might have been overlooked in this earlier study. The degree of posttranslational modification at Asn 51 may be functionally and clinically important because it is close to the CO17-1A mAb epitope (10) and to the proteolysis sensitivity site. Interestingly, different ratios of cleaved/noncleaved species of GA733-2 antigen were observed from different epithelial cell lines (33) . Although proteolytic regulation of the function of GA733-2 antigen has not been directly demonstrated, the possible correlation between proteolytic cleavage, glycosylation, and adhesion characteristics of the protein is an intriguing question for future studies.
A schematic model of the GA733-2 antigen based upon the data in this study is compared with previous models in Fig. 8 . (20) . Disulfide linkages for this protein have not been experimentally determined (shown as dashed lines). However, the linkages are expected to be the same as for the human insulin-like growth factor-binding proteins 1 and 6 (hIGFBP-1,6) domains. Note that the spacings between linked cysteines in hthyroglobulin motifs are highly variable whereas the spacings between adjacent disulfide linked pairs are highly conserved. Experimentally determined disulfide linkages and cysteine spacings for human insulin-like growth factor-binding proteins 1 and 6 (23) are shown for comparative purposes. A generic EGF-like cysteine-rich motif was derived from alignments using the EGF-like sequences for which three-dimensional structures were available (36) . Experimentally determined disulfide linkages for human tumor necrosis factor-binding protein (hTNFBP) are also shown (37) . The laminin type EGF-like (LE) motifs have similar disulfide linkages to those of EGF-like motifs, although they contain eight cysteines instead of six cysteines. Disulfide linkages of human epidermal growth factor receptor (hEGFR) and mouse laminin ␥1 chain (mLaminin ␥1 domain) were experimentally determined previously (36, 38) .
In all models, the location of the protease sensitive site is indicated with an arrow. The early model by Schon et al. (34) predicted that multiple disulfide bonds linked the small Nterminal fragment to the larger fragment after cleavage in the protease sensitive loop. In addition, three glycosylation sites on the larger fragment were predicted with no glycosylation of the small fragment. Recently, Balzar et al. (10) predicted that the cysteine-rich region is comprised of two tandem EGF-like motifs rather than the previously predicted EGF-like motif followed by a thyroglobulin type 1A motif (19, 20) . In contrast, our current model (Fig. 8) is based upon the disulfide bond structure and glycosylation sites established in the present study and delineate at least three distinct structural domains.
In conclusion, we have determined the disulfide bond linkages and glycosylation sites in the human gastrointestinal carcinoma GA733-2 antigen. The extracellular portion of this protein is comprised of at least three distinct motifs; an Nterminal six-cysteine motif with a unique disulfide linkage pattern (GA733 type 1 motif), a six-cysteine motif with the same disulfide linkage as thyroglobulin type 1A motifs (GA733 type 2 motif ϭ thyroglobulin type 1A motif), and a larger cysteine-free motif with no apparent homology to other proteins outside the GA733 protein family. Among the three potential N-glycosylation sites, Asn 88 and Asn 51 were found to have complete and partial glycosylation, respectively, whereas no glycosylation was found on Asn
175
. There was no evidence of O-linked glycosylation. Knowledge of the disulfide bonds and locations of the carbohydrate moieties of GA733-2 antigen provides a basis for further structural and functional studies of this protein and will aid in rational design of mutations in this protein.
